JVMCX
Price
$29.06
Change
+$0.01 (+0.03%)
Updated
Jul 31 closing price
Net Assets
23.61B
LYRIX
Price
$33.53
Change
-$0.01 (-0.03%)
Updated
Jul 31 closing price
Net Assets
1.31B
Interact to see
Advertisement

JVMCX vs LYRIX

JVMCX vs LYRIX Comparison Chart in %
View a ticker or compare two or three
VS
JVMCX vs. LYRIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Hold and LYRIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 23.6B vs. LYRIX (1.31B). LYRIX pays higher dividends than JVMCX: LYRIX (0.15) vs JVMCX (0.00). JVMCX was incepted earlier than LYRIX: JVMCX (15 years) vs LYRIX (14 years). JVMCX (1.86) is less costly to investors than LYRIX (0.98). JVMCX is a more actively managed with annual turnover of: 48.00 vs. LYRIX (32.00). JVMCX has a lower initial minimum investment than LYRIX: JVMCX (1000) vs LYRIX (100000). LYRIX annual gain was more profitable for investors over the last year : 17.37 vs. JVMCX (7.03). LYRIX return over 5 years is better than : 58.41 vs. JVMCX (9.14).
JVMCXLYRIXJVMCX / LYRIX
Total Expense Ratio1.850.99187%
Annual Report Gross Expense Ratio1.860.98190%
Fund Existence15 years14 years-
Gain YTD13.60416.18284%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets23.6B1.31B1,796%
Annual Yield % from dividends0.000.15-
Returns for 1 year7.0317.3741%
Returns for 3 years13.8061.9022%
Returns for 5 years9.1458.4116%
Returns for 10 years47.16130.5436%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BCEMX33.340.31
+0.94%
Boston Common ESG Impact Em Mkts
FWWFX41.880.26
+0.62%
Fidelity Worldwide
BAUAX31.950.07
+0.22%
Brown Advisory Small-Cap Fdmtl Val Adv
PEQSX44.95-0.03
-0.07%
Putnam Large Cap Value R6
HSRUX31.08-0.09
-0.29%
Carillon Eagle Small Cap Growth R6